Theravance Biopharma Inc. (TBPH)
Market Closed
17 Jul, 20:00
$
16. 93
-0.04
-0.2357%
$
877.45M Market Cap
- P/E Ratio
- Div Yield
449,500 Volume
-0.97 Eps
$ 16.97
Previous Close 
Want to track TBPH and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Theravance Biopharma Inc. (TBPH) Statistics
Valuation metrics
Market Cap 877.45M
Enterprise value 662.65M
Trailing P/E (ttm) 7.48
Forward P/E 12.27
PEG ratio 0
Price/Sales (ttm) 7.99
Price/Book (mrq) 2.99
Enterprise Value/Revenue 6.04
Enterprise Value/EBITDA 4.65
Overview
Shares outstanding 51.07M
Float 24.13M
Shares short 5.26M
% Held by insiders 0.04%
% Held by institutions 0.98%
Average volume (10 days) 446.52K
Average volume (90 days) 515.94K
Price summary
52-Week low 10.82
52-Week high 21.03
Beta 0.17
50-Day moving average 16.85
200-Day moving average 17.26
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin 1.04%
Operating margin 0%
Operational effectiveness
Return on assets 0.24%
Return on equity 0.44%
Income Statement
Revenue (ttm) 107.46M
Revenue per share (ttm) 2.14
Quarterly revenue growth (yoy) 1.45%
Gross profit (ttm) 70.05M
EBITDA 59.38M
Net income to common (ttm) 105.89M
Diluted EPS (ttm) 2.23
Quarterly earnings growth (yoy) 1.45%
Balance Sheet
Total cash (mrq) 315.36M
Total cash per share (mrq) 7.7
Total debt (mrq) 42.7M
Total Debt/Equity (mrq) 0.25
Current ratio (mrq) 13.14%
Book value per share (mrq) 5.67
Cash Flow
Cash flow statement 238.54M
Levered free cash flow (LFCF) -4.12M
